Get started
Author

Alireza Azimi

Observed names: A Azimi, A. Azimi
ORCID: 0000-0002-7398-5643
Observed ORCID: 0000-0002-7398-5643
OpenAlex ID: A5069526269
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel
2015 · Pedram Kharaziha, Dimitris Chioureas, et al. · Oncotarget · 149
PDF
Enhanced validation of antibodies for research applications
2018 · Fredrik Edfors, Andreas Hober, et al. · Nature Communications · 104
PDF
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
2019 · Soudabeh Rad Pour, Hiromasa Morikawa, et al. · Scientific Reports · 84
PDF
Polo-like kinases and acute leukemia
2018 · Oksana Goroshchuk, Iryna Kolosenko, et al. · Oncogene · 74
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
2018 · Alireza Azimi, Stefano Caramuta, et al. · Molecular Systems Biology · 68
PDF
Human endometrial stem cell neurogenesis in response to NGF and bFGF
2012 · Mahdi Noureddini, Javad Verdi, et al. · Cell Biology International · 50
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
2017 · Alireza Azimi, Rainer Tuominen, et al. · Cell Death and Disease · 46
PDF
Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance
2014 · A Azimi, M Pernemalm, et al. · British Journal of Cancer · 43
PDF
Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall
2013 · Alireza Shoae-Hassani, Seyed Abdolreza Mortazavi-Tabatabaei, et al. · Journal of Tissue Engineering and Regenerative Medicine · 39
Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats
2011 · Carolina Gustavsson, Tomoyoshi Soga, et al. · Journal of Molecular Endocrinology · 29
PDF
Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays
2022 · Ehsan Manouchehri Doulabi, Claudia Fredolini, et al. · Communications Biology · 24
PDF
Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines
2013 · Carolina Hertzman Johansson, Alireza Azimi, et al. · Melanoma Research · 24
Thermal proteome profiling identifies PIP4K2A and ZADH2 as off‐targets of Polo‐like kinase 1 inhibitor volasertib
2021 · Oksana Goroshchuk, Iryna Kolosenko, et al. · The FASEB Journal · 13
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
2021 · Linda Vidarsdottir, Alireza Azimi, et al. · Scientific Reports · 12
PDF
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib
2020 · Linda Vidarsdottir, Rita Valador Fernandes, et al. · Melanoma Research · 6
PDF
P2.17 Proteomics and Gene Expression Profiling of Melanoma Chemotherapy Response in Tumors
2012 · C. Hertzman Johansson, A. Azimi, et al. · Annals of Oncology · 3
PDF
Human proteins incorporated into tick-borne encephalitis virus revealed by in situ proximity ligation
2020 · Ryoyo Ikebuchi, Alfred W. Isaac, et al. · Biochemical and Biophysical Research Communications · 2
PDF
Palbociclib CDK4/6- and Crizotinib MET/ALK/ROS1-inhibitors Synergize to Enhance Senescence and Immune Recognition in Melanoma Cells Independently of BRAF / NRAS Status
2025 · Fan Zhang, Lola Boutin, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Investigation of AMBRA1 as a melanoma susceptibility gene
2017 · V. Hoeiom, M. Yang, et al. · Annals of Oncology
Unravelling molecular mechanisms underlying therapy resistance in cutaneous melanoma
2016 · Alireza Azimi · Figshare
Abstract B28: PTENpg1 antisense RNA mediates PTEN suppression in vemurafenib resistance and predicts clinical outcome in melanoma patients
2016 · Linda Vidarsdottir, Alireza Azimi, et al. · Cancer Research
140 Unraveling BRAF Inhibitor (PLX4032) Resistance Mechanisms
2012 · A. Azimi, C. Hertzman Johansson, et al. · European Journal of Cancer
P2.01 Characterization of Resistance Mechanisms To The Braf Inhibitor Vemurafenib (PLX4032)
2012 · A. Azimi · Annals of Oncology
P2.04 Effects of Combined Exposure To Braf and Pi3K Inhibitors With Chemotherapeutic Agents
2012 · S. Egyhazi, A. Azimi, et al. · Annals of Oncology
Abstract 3495: Targeted therapies in melanoma – in vitro effects of single and combined drug treatment
2011 · Alireza Azimi, Suzanne Egyházi, et al. · Cancer Research
Works count: 25
Citation count: 770
H-index: 13
I10-index: 14
Year
Topic
Type